📊 QGAI Key Takeaways
Is Quantumzyme Corp. (QGAI) a Good Investment?
QGAI is technically insolvent with negative stockholders equity of -$418.3K and zero revenue generation. The company has only $59 in cash against $418.4K in liabilities and is burning cash with -$43.8K in operating cash flow, indicating imminent insolvency without immediate capital injection.
Why Buy Quantumzyme Corp. Stock? QGAI Key Strengths
- Minimal technical assets exist ($59 cash)
- Classified in industrial chemicals sector which has market demand
- No recent insider selling activity indicates insiders may be resigned
QGAI Stock Risks: Quantumzyme Corp. Investment Risks
- Negative stockholders equity (-$418.3K) - company is balance sheet insolvent
- Zero revenue with -$4.4M net loss - no business operations
- Current ratio of 0.00x - unable to meet short-term liabilities of $418.4K with $59 cash
- Negative operating cash flow (-$43.8K) - actively burning capital
- Free cash flow deeply negative (-$55.7K) - value destruction with no recovery path
- Zero insider filings in 90 days - lack of confidence or activity
Key Metrics to Watch
- Stockholders equity trend toward positive territory
- Revenue generation and operating breakeven achievement
- Cash position and runway until capital depletion
- Form 4 insider activity indicating conviction or exit
Quantumzyme Corp. (QGAI) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
QGAI Profit Margin, ROE & Profitability Analysis
QGAI vs Materials Sector: How Quantumzyme Corp. Compares
How Quantumzyme Corp. compares to Materials sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Quantumzyme Corp. Stock Overvalued? QGAI Valuation Analysis 2026
Based on fundamental analysis, Quantumzyme Corp. has mixed fundamental signals relative to the Materials sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Quantumzyme Corp. Balance Sheet: QGAI Debt, Cash & Liquidity
QGAI Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Quantumzyme Corp.'s revenue has declined by 100% over the 5-year period, indicating business contraction. The most recent EPS of $-0.01 indicates the company is currently unprofitable.
QGAI Revenue Growth, EPS Growth & YoY Performance
QGAI Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | N/A | -$29.8K | $0.00 |
| Q1 2026 | N/A | -$49.9K | $0.00 |
| Q3 2025 | N/A | -$6.0K | N/A |
| Q1 2018 | $30.6K | -$2.1K | N/A |
| Q1 2017 | $30.1K | -$1.9K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Quantumzyme Corp. Dividends, Buybacks & Capital Allocation
QGAI SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Quantumzyme Corp. (CIK: 0001663038)
📋 Recent SEC Filings
❓ Frequently Asked Questions about QGAI
What is the AI rating for QGAI?
Quantumzyme Corp. (QGAI) has an AI rating of STRONG SELL with 98% confidence, based on fundamental analysis of SEC EDGAR filings.
What are QGAI's key strengths?
Claude: Minimal technical assets exist ($59 cash). Classified in industrial chemicals sector which has market demand.
What are the risks of investing in QGAI?
Claude: Negative stockholders equity (-$418.3K) - company is balance sheet insolvent. Zero revenue with -$4.4M net loss - no business operations.
What is QGAI's revenue and growth?
Quantumzyme Corp. reported revenue of $0.0.
Does QGAI pay dividends?
Quantumzyme Corp. does not currently pay dividends.
Where can I find QGAI SEC filings?
Official SEC filings for Quantumzyme Corp. (CIK: 0001663038) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is QGAI's EPS?
Quantumzyme Corp. has a diluted EPS of $-0.11.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is QGAI a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Quantumzyme Corp. has a STRONG SELL rating with 98% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is QGAI stock overvalued or undervalued?
Valuation metrics for QGAI: ROE of N/A (sector avg: 14%), net margin of N/A (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy QGAI stock in 2026?
Our dual AI analysis gives Quantumzyme Corp. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is QGAI's free cash flow?
Quantumzyme Corp.'s operating cash flow is $-43.8K, with capital expenditures of $11.9K.
How does QGAI compare to other Materials stocks?
Vs Materials sector averages: Net margin N/A (avg: 10%), ROE N/A (avg: 14%), current ratio 0.00 (avg: 1.6).